5 Notable Health Tech Funding Announcements in February
Health tech companies made several major funding announcements in February. Here is a list of some of the biggest funding rounds.
Health tech companies made several major funding announcements in February. Here is a list of some of the biggest funding rounds.
Telepsychiatry provider Talkiatry has raised a $210 million Series D round led by Perceptive Advisors, bringing its total funding to more than $400 million. CEO Robert Krayn said the company is focused on scaling its clinician-employed model and improving outcomes as competition intensifies across behavioral health and virtual care.
The DEA recently released three rules regarding the remote prescribing of controlled substances. However, many telehealth advocates argue that two of these rules hinder access to care.
The DEA recently announced the third extension of Covid-19 flexibilities for the virtual prescribing of controlled substances. Telehealth advocates applaud this move but remain hopeful for a more permanent solution in the future.
Through a new partnership, employees of BetterHelp’s employer clients can access Talkiatry’s psychiatry services on an in-network basis at no extra cost.
Here is a list of some of the biggest funding rounds in the payer/employer space that were announced in June.
In a landscape where complexity has long been the norm, the power of one lies not just in unification, but in intelligence and automation.
Talkiatry's funding round was led by Andreessen Horowitz. With the financing, the company will bring on more providers and advance value-based care.
Through a new partnership, Talkiatry patients who need more intensive care will be able to step up to treatment with Charlie Health. Then Charlie Health patients who no longer require intensive care can step down to Talkiatry to receive ongoing psychiatric care.
Talkiatry, Array Behavioral Care, Iris Telehealth and Quartet Health sent a letter to the DEA asking for a special registration process that would allow for the prescribing of certain controlled medications via telemedicine.
Talkiatry and NOCD are teaming up to improve care for patients with obsessive-compulsive disorder. Talkiatry specializes in medication management, while NOCD specializes in Exposure and Response Prevention therapy.
Talkiatry is now available to Horizon Healthcare Services’ commercial members at no additional cost, giving 3.6 million people access to the virtual mental health services. The company treats patients ages 5 years and older for conditions including anxiety, depression and bipolar disorder.
In the third quarter of 2022, BCBS Massachusetts’ members had about 8 million behavioral health visits, compared to about 4 million in 2019. In response, the insurer is expanding its mental health services by contracting with Talkiatry, And Still We Rise and DynamiCare.